This is the resubmission of a highly successful training grant funded for 30 years from the Department of Dermatology at the University of Colorado Anschutz Medical Campus (UCAMC). This program began as an Immunodermatology training vehicle, but has greatly changed in the past 15 years as the research focus in this Department has broadened. The remarkable expansion of the research program in the Department of Dermatology at UCAMC provides a perfect opportunity to restructure the scope and focus of this training grant, which has been unfunded since 2012. Dennis Roop, the new PI, will lead an impressive multidisciplinary team of trainers and mentors, 16 of 24 of the current training faculty are new. This team of trainers and mentors will provide a 2 year training program for pre-doctoral and postdoctoral trainees. The focus of this training grant will be similar to tha of our NIAMS-funded P30 UCAMC-SDRC entitled Molecular Analysis, Modeling and Correction of Skin Diseases. This SDRC emphasizes understanding the molecular basis of human autoimmune, inflammatory, developmental, metabolic and genetic skin diseases and development of genetically engineered mouse models which mimic these disorders at both the genetic and phenotypic levels. Further, preclinical models (including mouse models) will be utilized to assess the feasibility of stem cell approaches to therapy. Historically, this has beena highly successful training grant, preparing clinical scientists for academic careers, stimulating extensive research collaborations between scientists in Dermatology and other departments, and supporting a highly productive research program in the Department of Dermatology. Of the 24 trainees who have completed a 2 year research fellowship between 1984 and 2006, 14 (58%) initially obtained academic appointments, two have continued research in other settings, and 8 have entered private practice. Six have current faculty positions at UCAMC. Of the 7 trainees since 2007, 6 are in other research positions after completing training. One of these is an assistant professor in the Department of Dermatology and has obtained K01 funding, as well as funding from 3 other local and national sources. The overall objective of this program is to prepare trainees for a successful academic career in cutaneous biology research at academic institutions. Our program will primarily train postdoctoral fellows (PhD, MD and MD/PhD) to prepare them for successful transitions into independent research funding and eventually independent research careers. This training grant will support 2 pre-doctoral and 4 postdoctoral training positions per year. Research training in preceptor's labs will be supplemented with a substantial program of enrichment including research seminars, research in progress, didactic lectures on relevant topics, and training in ethics. Recruitment of candidates for this program wil be managed by a well-organized administrative structure and will include a robust plan to attract underserved minorities.

Public Health Relevance

The support for training of young scientists and clinicians for future careers in research is a fundamental part of the NIAMS mission. The broad scope of this training program in many areas of cutaneous biology and skin diseases, combined with a focus on regenerative medicine and stem cell biology, are also ideal for NIAMS support.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32AR007411-31A1
Application #
8856000
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Cibotti, Ricardo
Project Start
1981-07-01
Project End
2020-06-30
Budget Start
2015-07-01
Budget End
2016-06-30
Support Year
31
Fiscal Year
2015
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Dermatology
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Kogut, Igor; McCarthy, Sandra M; Pavlova, Maryna et al. (2018) High-efficiency RNA-based reprogramming of human primary fibroblasts. Nat Commun 9:745
Zhai, Z; Liu, W; Kaur, M et al. (2017) NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma. Oncogene 36:3820-3830
Shellman, Yiqun G; Lambert, Karoline A; Brauweiler, Anne et al. (2015) SASH1 Is Involved in an Autosomal Dominant Lentiginous Phenotype. J Invest Dermatol 135:3192-3194
Mukherjee, Nabanita; Reuland, Steven N; Lu, Yan et al. (2015) Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cells. J Invest Dermatol 135:842-850
Reuland, Steven N; Smith, Shilo M; Bemis, Lynne T et al. (2013) MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD). J Invest Dermatol 133:1286-93
Reuland, Steven N; Goldstein, Nathaniel B; Partyka, Katie A et al. (2012) ABT-737 synergizes with Bortezomib to kill melanoma cells. Biol Open 1:92-100
Reuland, Steven N; Goldstein, Nathaniel B; Partyka, Katie A et al. (2011) The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53. PLoS One 6:e24294
Ellis, Lixia Z; Liu, Weimin; Luo, Yuchun et al. (2011) Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1? secretion. Biochem Biophys Res Commun 414:551-6
Anwar, Adil; Norris, David A; Fujita, Mayumi (2011) Ubiquitin proteasomal pathway mediated degradation of p53 in melanoma. Arch Biochem Biophys 508:198-203
Okamoto, Miyako; Liu, Weimin; Luo, Yuchun et al. (2010) Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem 285:6477-88

Showing the most recent 10 out of 55 publications